We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A recent Europe-wide review of the safety information for alli has led to a number of updates, which bring the product information in line with that for Xenical.
This is an evidence based toolkit to support dental teams in improving their patient’s oral and general health.
This guidance is issued jointly by the Department of Health and Social…
Information for healthcare professionals and the public about Lagevrio
Summary of Product Characteristics This medicinal product is subject to…
Package leaflet: Information for the user Lagevrio 200 mg hard capsules…
Information you must provide in your application to deploy mobile plant for landspreading waste. How you must operate under your approved deployment.
Employment Tribunal decision.
EAMS scientific opinion issued to Global Blood Therapeutics (UK) Ltd for Voxelotor in the treatment of haemolytic anaemia due to sickle cell disease (SCD) in adults and paediatric patients 12 years of age and older as monoth…
Residential Property Tribunal Decision of Judge Robert Latham and John Naylor FRICS FIRPM on 12 March 2024
The farm animal genetic resources (FAnGR) committee's review of current and new technologies, including genomics.
Information for healthcare professionals and the public about Paxlovid
We're looking for your views on how medical devices will be regulated across the United Kingdom (UK) in the future.
EAMS scientific opinion issued to Bristol-Myers Squibb Pharmaceuticals Limited for nivolumab to be used in combination with ipilimumab in the treatment of malignant pleural mesothelioma (a type of cancer that affects the lin…
Competent authorities of exporting countries should use the relevant model health certificate as a template to create a version exporters can apply for to export fats to Great Britain, the Channel Islands or Isle of Man.
Forms for the notification of serious undesirable effects (SUEs) from cosmetic products in Great Britain.
Information on how to report a serious undesirable effect (SUE) or safeguarding issue for cosmetic products.
This is a list of all the opinions the RPC issued in 2019 on Department of Health and Social Care measures.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).